Assessment of protein biomarkers for preoperative differential diagnosis between benign and malignant ovarian tumors
Landolfo, C., Achten, E.T.L., Ceusters, J., Baert, T., Froyman, W., Heremans, R., Vanderstichele, A., Thirion, G., Van Hoylandt, A., Claes, S., Oosterlynck, J., Van Rompuy, A.S., Schols, D., Billen, J., Van Calster, B., Bourne, T., Van Gorp, T., Vergote, I., Timmerman, D., Coosemans, A.
Published in Gynecologic oncology (01.12.2020)
Published in Gynecologic oncology (01.12.2020)
Get full text
Journal Article
Preoperative c-reactive protein and thrombocyte count as potential markers for longterm survival in ovarian cancer
Braicu, E.I., Sehouli, J., Richter, R., Vergote, I.B., Concin, N., van Nieuwenhuysen, E., Achimas, P., Berger, A., Fetica, B., Mahner, S., Glajzer, J., Papadia, A., Woelber, L., Gasparri, M.L., Vanderstichele, A., Benedetti Panici, P., Mueller, M., Ruscito, I., Zimmer, J., Woopen, H.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
OC20.01: Can determination of immune cells help in the preoperative ultrasound assessment of ovarian cancer? A pilot study
Coosemans, A., Landolfo, C., Baert, T., Vanderstichele, A., Froyman, W., Busschaert, P., Vergote, I., Van Calster, B., Timmerman, D.
Published in Ultrasound in obstetrics & gynecology (01.09.2016)
Published in Ultrasound in obstetrics & gynecology (01.09.2016)
Get full text
Journal Article
Metastasis-directed therapy for oligorecurrent prostate cancer: Oncological outcomes of a tertiary referral centre
Devos, G., Vanderstichele, A., Van Eecke, H., Berghen, C., Muilwijk, T., Roussel, E., Clinckaert, A., Albersen, M., Hendrik, V.P., Everaerts, W., De Meerleer, G., Joniau, S.
Published in European urology open science (Online) (01.07.2020)
Published in European urology open science (Online) (01.07.2020)
Get full text
Journal Article
Patient and region based accuracy of PSMA PET/CT in patients undergoing salvage lymphadenectomy for lymph node recurrence following primary treatment
Devos, G., Vanderstichele, A., Van Eecke, H., Berghen, C., Muilwijk, T., Roussel, E., Clinckaert, A., Albersen, M., Van Poppel, H., Everaerts, W., De Meerleer, G., Joniau, S.
Published in European urology open science (Online) (01.07.2020)
Published in European urology open science (Online) (01.07.2020)
Get full text
Journal Article
Randomized phase II CLIO study on olaparib monotherapy versus chemotherapy in platinum-sensitive recurrent ovarian cancer
Loverix, L., Vanderstichele, A., Olbrecht, S., Van Niewenhuysen, E., Van Gorp, T., Han, S.N., Salihi, R., Concin, N., Neven, P., Busschaert, P., Lambrechts, D., Vergote, I.
Published in Gynecologic oncology (01.10.2020)
Published in Gynecologic oncology (01.10.2020)
Get full text
Journal Article
Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan
Salk, Jesse J., Loubet-Senear, Kaitlyn, Maritschnegg, Elisabeth, Valentine, Charles C., Williams, Lindsey N., Higgins, Jacob E., Horvat, Reinhard, Vanderstichele, Adriaan, Nachmanson, Daniela, Baker, Kathryn T., Emond, Mary J., Loter, Emily, Tretiakova, Maria, Soussi, Thierry, Loeb, Lawrence A., Zeillinger, Robert, Speiser, Paul, Risques, Rosa Ana
Published in Cell reports (Cambridge) (02.07.2019)
Published in Cell reports (Cambridge) (02.07.2019)
Get full text
Journal Article
817P Response to olaparib monotherapy in relapsed ovarian cancer by HRR gene mutational status and HRD scarring analysis: Results from the randomized phase II CLIO trial
Vanderstichele, A., Loverix, L., De Vogelaere, C., Heyrman, L., Van Gorp, T., Van Nieuwenhuysen, E., Han, S., Olbrecht, S.J.A.R., Berteloot, P., Neven, P., Schepers, R., Busschaert, P., Goossens, D., Lambrechts, D., Vergote, I.B.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
P115 Quality-of-life analysis in the randomized phase II CLIO trial comparing olaparib with standard chemotherapy in platinum-resistant recurrent ovarian cancer
Callewaert, T, Vanderstichele, A, Van Nieuwenhuysen, E, Han, S, Concin, N, Van Gorp, T, Berteloot, P, Neven, P, Busschaert, P, Lambrechts, D, Vergote, I
Published in International journal of gynecological cancer (01.11.2019)
Published in International journal of gynecological cancer (01.11.2019)
Get full text
Journal Article
964PPreoperative c-reactive protein and thrombocyte count as potential markers for longterm survival in ovarian cancer
Braicu, E I, Sehouli, J, Richter, R, Vergote, I B, Concin, N, van Nieuwenhuysen, E, Achimas, P, Berger, A, Fetica, B, Mahner, S, Glajzer, J, Papadia, A, Woelber, L, Gasparri, M L, Vanderstichele, A, Benedetti Panici, P, Mueller, M, Ruscito, I, Zimmer, J, Woopen, H
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
TP53 mutations in cell-free DNA as early markers of therapeutic response in platinum-resistant relapsed ovarian cancer (PROC): a prospective translational analysis of the phase II GANNET53 clinical trial
Vanderstichele, A, Concin, N, Busschaert, P, Braicu, I, Combe, P, Ray-Coquard, I, Joly, F, Harter, P, Wimberger, P, Selle, F, Ignatov, A, Schmalfeldt, B, Van Nieuwenhuysen, E, Darb-Esfahani, S, Zeimet, A, Mahner, S, Pujade-Lauraine, E, Marth, C, Berger, R, Sehouli, J, Moll, U, Zeillinger, R, Lambrechts, D, Vergote, I
Published in International journal of gynecological cancer (01.11.2019)
Published in International journal of gynecological cancer (01.11.2019)
Get full text
Journal Article
Ovarian cancer detection combining an innovative catheter for uterine and tubal lavage with ultra-sensitive TP53 sequencing
Speiser, P, Maritschnegg, E, Heitz, F, Pecha, N, Bouda, J, Trillsch, F, Grimm, C, Vanderstichele, A, Agreiter, C, Harter, P, Obermayr, E, Vergote, I, Zeillinger, R, Salk, JJ, Risques, RA, Austria, AGO
Published in International journal of gynecological cancer (01.11.2019)
Published in International journal of gynecological cancer (01.11.2019)
Get full text
Journal Article
Abstract P2-10-12: How well predict the 2011 St Gallen early breast cancer surrogate phenotypes metastatic survival?
Vanderstichele, A, Brouckaert, O, Tuyls, S, Amant, F, Leunen, K, Smeets, A, Berteloot, P, Van Limbergen, E, Weltens, C, Peeters, S, Moerman, P, Floris, G, Paridaens, R, Wildiers, H, Vergote, I, Christiaens, M-R, Van Calster, B, Neven, P
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article
Abstract P6-05-05: Triple receptor comparison between primary breast cancer and metachronous or synchronous liver metastasis
Tuyls, S, Brouckaert, O, Vanderstichele, A, Vanderhaegen, J, Amant, F, Leunen, K, Smeets, A, Berteloot, P, Van Limbergen, E, Weltens, C, Peeters, S, Vanbeckevoort, D, Floris, G, Moerman, P, Paridaens, R, Wildiers, H, Vergote, I, Christiaens, M-R, Neven, P
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article
Application of specific identification tau antibody, and reagent kit containing thereof
VANDERSTICHELE HUGO, VAN DE VOORDE ANDRE, VANMECHELEN EUGEEN, VANGOOL STEFAAN, HULSTAERT FRANK
Year of Publication 10.04.2013
Get full text
Year of Publication 10.04.2013
Patent
TAU AS A MARKER FOR EARLY CNS DAMAGE
STEFAAN VAN GOOL, EUGEEN VANMECHELEN, HUGO VANDERSTICHELE, ANDRE VAN DE VOORDE, FRANK HULSTAERT
Year of Publication 12.08.2005
Get full text
Year of Publication 12.08.2005
Patent